サイクリンA-Cdk2複合体と結合したp27Kip1サイクリン依存キナーゼ阻害体の結晶構造
A A Russo1, P D Jeffrey, A K Patten
1Cellular Biochemistry and Biophysics Program, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
Nature
|July 25, 1996
まとめ
結晶構造は,ヒトのp27Kip1タンパク質が,この複合体と結合することによって,サイクリンA-サイクリン依存キナーゼ2 (Cdk2) を抑制する方法を示しています. この相互作用は,Cdk2を再構成し,触媒裂口におけるATP結合を模倣する.
科学分野:
- 構造生物学 構造生物学とは
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
背景:
- サイクリン依存キナーゼ (CDK) は,細胞循環の重要な調節因子である.
- 異常なCDK活性が様々ながんと関連している.
- p27Kip1は,CDK活動の阻害剤として知られているが,その正確な結合メカニズムは不明のままである.
研究 の 目的:
- リン酸化サイクリンA-Cdk2複合体と結合したヒトp27Kip1キナーゼ阻害ドメインの高解像度結晶構造を決定する.
- サイクリンA-Cdk2.2のp27Kip1の抑制を制御する分子相互作用を解明する.
主な方法:
- 構造を決定するために,X線結晶学を用いた.
- 構造は2.3アングストロムの解像度で解きました.
主要な成果:
- 結晶構造は,p27Kip1がサイクリンA-Cdk2複合体を延長された形状として結合することを明らかにしています.
- p27Kip1は,サイクリンAとCdk2の両方と相互作用する.
- 特定の相互作用には,サイクリンAの溝に結合し,Cdk2のアミノ末端葉の再編成が含まれています.
- p27Kip1はCdk2の触媒裂け目に挿入し,ATP結合を模倣する.
結論:
- 決定された構造は,サイクリンA-Cdk2.2に対するp27Kip1の抑制メカニズムの詳細な分子基礎を提供します.
- この相互作用を理解することで,CDKの活動が調節不良に関連したがんの標的療法の開発に役立つ可能性がある.
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...